Know Cancer

or
forgot password

Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy: A Cardiac Magnetic Resonance and Biomarker Imaging and Serological Biomarker Study


N/A
9 Years
35 Years
Open (Enrolling)
Both
Cardiovascular Disease

Thank you

Trial Information

Defining Late Onset Occult Asymptomatic Cardiotoxicity in Childhood Cancer Survivors Exposed to Anthracycline Therapy: A Cardiac Magnetic Resonance and Biomarker Imaging and Serological Biomarker Study


Inclusion Criteria:



- Childhood cancer survivors from the late effect clinic who had been in continuous,
complete remission and off chemotherapy for a minimum of 2 years.

- Age > 9 years of age

Exclusion Criteria:

- Contraindications to CMRI

- Relapse of their cancer

- Pregnancy

Type of Study:

Observational

Study Design:

Observational Model: Case Control, Time Perspective: Cross-Sectional

Principal Investigator

Olga Salazar, MS

Investigator Role:

Principal Investigator

Investigator Affiliation:

Connecticut Childrens Med Ctr

Authority:

United States: Institutional Review Board

Study ID:

CardiacMRI

NCT ID:

NCT01671696

Start Date:

September 2011

Completion Date:

May 2014

Related Keywords:

  • Cardiovascular Disease
  • Cardiovascular Diseases

Name

Location

Connecticut Children's Medical CenterHartford, Connecticut  06106